Your browser doesn't support javascript.
loading
Aryl-urea fatty acids that activate the p38 MAP kinase and down-regulate multiple cyclins decrease the viability of MDA-MB-231 breast cancer cells.
Al-Zubaidi, Yassir; Pazderka, Curtis; Koolaji, Nooshin; Rahman, Md Khalilur; Choucair, Hassan; Umashankar, Bala; Bourget, Kirsi; Chen, Yongjuan; Rawling, Tristan; Murray, Michael.
Afiliación
  • Al-Zubaidi Y; Pharmacogenomics and Drug Development Group, Discipline of Pharmacology, School of Medical Sciences, Sydney Medical School, University of Sydney, NSW 2006, Australia.
  • Pazderka C; School of Mathematical and Physical Sciences, Faculty of Science, University of Technology, Sydney, Ultimo, NSW 2007, Australia.
  • Koolaji N; Pharmacogenomics and Drug Development Group, Discipline of Pharmacology, School of Medical Sciences, Sydney Medical School, University of Sydney, NSW 2006, Australia.
  • Rahman MK; Pharmacogenomics and Drug Development Group, Discipline of Pharmacology, School of Medical Sciences, Sydney Medical School, University of Sydney, NSW 2006, Australia.
  • Choucair H; Pharmacogenomics and Drug Development Group, Discipline of Pharmacology, School of Medical Sciences, Sydney Medical School, University of Sydney, NSW 2006, Australia.
  • Umashankar B; Pharmacogenomics and Drug Development Group, Discipline of Pharmacology, School of Medical Sciences, Sydney Medical School, University of Sydney, NSW 2006, Australia.
  • Bourget K; Pharmacogenomics and Drug Development Group, Discipline of Pharmacology, School of Medical Sciences, Sydney Medical School, University of Sydney, NSW 2006, Australia.
  • Chen Y; Pharmacogenomics and Drug Development Group, Discipline of Pharmacology, School of Medical Sciences, Sydney Medical School, University of Sydney, NSW 2006, Australia.
  • Rawling T; School of Mathematical and Physical Sciences, Faculty of Science, University of Technology, Sydney, Ultimo, NSW 2007, Australia.
  • Murray M; Pharmacogenomics and Drug Development Group, Discipline of Pharmacology, School of Medical Sciences, Sydney Medical School, University of Sydney, NSW 2006, Australia. Electronic address: michael.murray@sydney.edu.au.
Eur J Pharm Sci ; 129: 87-98, 2019 Mar 01.
Article en En | MEDLINE | ID: mdl-30597206
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Urea / Neoplasias de la Mama / Supervivencia Celular / Ciclinas / Sistema de Señalización de MAP Quinasas / Proteínas Quinasas p38 Activadas por Mitógenos / Ácidos Grasos Límite: Female / Humans Idioma: En Revista: Eur J Pharm Sci Asunto de la revista: FARMACIA / FARMACOLOGIA / QUIMICA Año: 2019 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Urea / Neoplasias de la Mama / Supervivencia Celular / Ciclinas / Sistema de Señalización de MAP Quinasas / Proteínas Quinasas p38 Activadas por Mitógenos / Ácidos Grasos Límite: Female / Humans Idioma: En Revista: Eur J Pharm Sci Asunto de la revista: FARMACIA / FARMACOLOGIA / QUIMICA Año: 2019 Tipo del documento: Article País de afiliación: Australia